Articles On Oncosil Medical (ASX:OSL)
Title | Source | Codes | Date |
---|---|---|---|
Top 10 at 10: ‘Outstanding’ lithium hits and a $30m ADF cash splash
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | OSL | 2 weeks ago |
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | OSL | 2 weeks ago |
Market Update: Red flags dot ASX landscape as living costs squeeze
The ASX200 is down 1.1 per cent – on par with futures’ predictions – with every sector flashing red mid-session. Meanwhile, the ABS has released international investment data and living cost indexes. Australia’s International Investme... |
themarketonline.com.au | OSL | 2 weeks ago |
OncoSil’s cancer device shows shrink in pancreatic tumours
OncoSil Medical (ASX:OSL) released groundbreaking findings from a study which showed that the addition of OncoSil™ to systemic chemotherapy returned an increase in the vascularity of the primary pancreatic tumors, and at the same time: resu... |
themarketonline.com.au | OSL | 2 weeks ago |
Market Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US report
ASX to open sharply lower as Wall Street spooked by strong US jobs data Cannabis stocks jumped after the US DEA downscheduled pot Amazon popped on top and bottom lines beat Aussie shares are poised to open sharply lower on Wednesday... |
Stockhead | OSL | 2 weeks ago |
Closing Bell: ASX finds some bulldog as copper-gold pup Canterbury pops, just like we said it would
The ASX belts one out on Monday, up 0.8pc All 11 sectors are better for it Canterbury Resources grows by half The benchmark Aussie index has started the week with decisive and broad based gains. All 11 sectors ended Monday higher. US Fu... |
Stockhead | OSL | 2 weeks ago |
Top 10 at 10: This scorching hot explorer is up 200% in a week
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | OSL | 2 weeks ago |
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | OSL | 3 weeks ago |
Closing Bell: ASX’s gains erased after strong CPI, winning tickers today include WMS and OZM
The ASX pared gains after the CPI came in stronger than expected Fortescue led the Mining sector after its quarterly update TikTok’s ban in the US looms The ASX closed modestly higher today by +0.1% as gains were pared after the release... |
Stockhead | OSL | 3 weeks ago |
Top 10 at 10: Check out these 42% nickel veinlets
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | OSL | 3 weeks ago |
Closing Bell: Tech stocks in demand ahead of Tesla results; Osteopore up 130pc on clinical trial news
The ASX extends its gains on Tuesday Tech stocks rallied ahead of US megacap earnings, while goldies struggled Tesla, along with Alphabet and Spotify, will release results tonight The ASX200 lifted on Tuesday, up by +0.45% after trackin... |
Stockhead | OSL | 3 weeks ago |
Top 10 at 10: Here comes this project’s first gold drilling program in over a decade
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | OSL | 4 weeks ago |
First Turkish patient treated with OncoSil cancer treatment device
Pancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has announced the first treatment utilising the OncoSil device on a patient residing in Turkey. |
BiotechDispatch | OSL | 1 month ago |
Top 10 at 10: Piedmont gets green light to build ‘one of the lowest cost, most sustainable lithium hydroxide operations in the world’
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | OSL | 1 month ago |
OncoSil doses first patient with OncoSilTM to advance pancreatic cancer treatment trials
OncoSil Medical (ASX:OSL), in its ongoing mission to develop treatments for pancreatic cancer, says the first patient treatment using the OncoSilTM device for its TRIPP-FXX clinical study has been conducted at the prestigious Hammersmith Ho... |
themarketonline.com.au | OSL | 1 month ago |
Closing Bell: Gains in Gold and Tech stocks offset by losses in Energy as oil price retreats
The ASX200 closed up slightly by +0.1% on Monday as gains in tech and gold stocks were offset by losses in the energy sector. Energy stocks struggled as crude prices fell more than US$1 a barrel in Asian hours today after Israel confirmed... |
Stockhead | OSL | 1 month ago |
Market close: ASX slips with IT seeing out the week in headwinds
The ASX200 has closed down .56 of a per cent with IT down 1.4 per cent and in the red for a second straight day, materials slumping 0.8 per cent and real estate shedding .61 per cent. Coming into sharp focus today were OncoSil Medical, T... |
themarketonline.com.au | OSL | 1 month ago |
Market update: ASX edges down with energy bouyant in a sea of red
The ASX200 is down nearly .7 of a per cent – almost on par with futures’ predictions – with most sectors, apart from energy, in the red. The Australian Bureau of Statistics released data showing that imported goods rose by 4.8 per cent i... |
themarketonline.com.au | OSL | 1 month ago |
OncoSil Medical doses patients in Austria and expands worldwide
OncoSil Medical (ASX:OSL) – on its mission to combat pancreatic cancer – has now dosed the first two patients in Austria with the use of the OncoSilTM device. In early trade Oncosil shares catapulted as much as 30 per cent after announci... |
themarketonline.com.au | OSL | 1 month ago |
Closing Bell: ASX too timid on Tuesday. Although Dart Mining has a decent Mesoblast
The ASX200 ends Tuesday slightly lower Resources stocks hold the fort, everyone else AWOL Small Caps led by Dart Mining and Mesoblast Local stocks looked the goods during the first hour of the new quarter, but that – like the ASX200’s... |
Stockhead | OSL | 1 month ago |
Top 10 at 11: Little diggers turn up value as lithium, gold finds continue
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | OSL | 1 month ago |
Closing Bell: ASX loses its bottle, but Gold50 shows some Gallium to advance 50pc
The ASX200 has ended Friday down 0.15pc, but ends week higher Property and Healthcare gains offset by Resources losses Small Caps led by Gold50 Wall Street hit more record highs on Thursday in New York, the Australian market on Friday,... |
Stockhead | OSL | 1 month ago |
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr... |
Stockhead | OSL | 2 months ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | OSL | 2 months ago |
Closing Bell: ASX200 flat and earthbound as Nyrada CEO exclusively shares 3 reasons for stunning 420pc session
Local markets end hopelessly, slightly lower IT sector surges 2.9% Small Caps led by incredible Nyrada outperformance Despite a return to form for lithium and a stunning 420% rally for little local drugmaker Nyrada, the ASX200 was t... |
Stockhead | OSL | 2 months ago |
Closing Bell: The ASX has come a long way and gone nowhere on Monday
Local markets are lucky to close a smidgen higher IT and Healthcare sectors offset a 2pc loss for Energy Small Caps led by Enova Mining Australian sharemarkets lacked all the vim, vigour and vinegar one associates with victory on Mond... |
Stockhead | OSL | 2 months ago |
Closing Bell: Aussie benchmark fails Tuesday pub test. We should all be there now
Local markets end slightly lower Telco Sector jumps 1.5pc Small Caps led by Way2Vat The ASX200 has ended a second slumbrous session slightly lower, with a little dribble in the shape of the Star Casino at the corner of its mouth. US M... |
Stockhead | OSL | 2 months ago |
Closing Bell: Material gains for the ASX on Friday while a good week at work sees Tech Sector gain 7.5pc
ASX adds 0.7pc to close out the week in a positive frame of mind IT and materials rise, thanks to a softening US dollar and general commodity weirdness Small caps led by NKOTB, Australian Wealth Advisors Group on a solid debut Materi... |
Stockhead | OSL | 3 months ago |
Closing Bell: ASX embraces Star Tech and Return of the Jobless
ASX rises 0.77pc, hefted heavenward with the help of a huge tech buy InfoTech was the best of the sectors, up 6.81pc by day’s end Small cap winners included James Bay Minerals, Bellavista Resources and Way2VAT Local markets have stru... |
Stockhead | OSL | 3 months ago |
Top 10 at 11: Lithium hits and AI are what’s driving the news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | OSL | 3 months ago |
Market Highlights: Dovish comments from Fed, gold nears all-time high, and 5 ASX small caps to watch
ASX to gain on Wednesday after dovish comments from US Fed Gold price continues to climb, nears all time high Deutsche Bank is positive about equities’ prospects in 2024 Aussie shares are poised to edge higher again on Wednesday after m... |
Stockhead | OSL | 5 months ago |
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
ASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing Allegra’s Spinal Cage Device made from 3D-printed Sr-HT-Gahnite Stockhead reached out to Allegra’s board member, Dr Nick Hartnell It’s b... |
Stockhead | OSL | 5 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | OSL | 6 months ago |
Closing Bell: Broad-based whinging leads ASX back to the start of 2023, minus the hope and ignorance
The ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Small caps led by 4DX, Infinity and a few Lake Johnston lithium plays The local market is back to digging its little hole from which it may t... |
Stockhead | OSL | 6 months ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | OSL | 6 months ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | OSL | 7 months ago |
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks On... |
Stockhead | OSL | 8 months ago |
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August August was all about earnings, and des... |
Stockhead | OSL | 8 months ago |
Check Up: Australian biotech sector continues to be a magnet for US investors
Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the best and worst performing ASX biotechs over the past month The Australian biotech sector co... |
Stockhead | OSL | 8 months ago |
Closing Bell: ASX200 makes it a hat-trick after Tech Sector triumph
ASX 200 benchmark rises almost 0.6% Tech Sector recovers Wednesday’s losses, after Nasdaq positivity Miners lead small cap gains, ERW, RDN, AZS winning at home in Andover South The Australian share market was up and about early on Thur... |
Stockhead | OSL | 8 months ago |
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month Steve Jobs used to say that the most... |
Stockhead | OSL | 9 months ago |
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July The Covid-19 pandemic had produced windfalls for and attracted fa... |
Stockhead | OSL | 9 months ago |
OncoSil Medical (ASX:OSL) gains ethics committee approval for PANCOSIL trial
OncoSil Medical (OSL) gains ethics committee approval for its PANCOSIL trial, focused on treating patients with locally advanced pancreatic cancer (LAPC) The company will recruit 15 patients for treatment using its OncoSil device via a p... |
themarketherald.com.au | OSL | 11 months ago |
ASX Health Stocks: OncoSil to commence trial; Korea and Malaysia next stops for these biotechs
OncoSil gets Ethics committee approval Starpharma’s nasal spray VIRALEZE granted approval in Malaysia Botanix Pharmaceuticals strikes deal in Korea Medical device OncoSil Medical (ASX:OSL) rose 8% this morning after the Ethics committe... |
Stockhead | OSL | 11 months ago |
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough
Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May There are clear signs the biotech sector is springing back to life after a disappointing 2... |
Stockhead | OSL | 11 months ago |
CLOSING BELL: Someone please give the market a nudge… I think it’s fallen asleep
The ASX fell this morning and – sadly – just never recovered. It’s down 0.64%. Aside from Happy Times among the lithium players, it’s been a total snoozefest Rubix Resources (ASX:RB6) takes bragging rights with a 41.6% hike for the day ... |
Stockhead | OSL | 11 months ago |
Oncosil Medical announces first patient treatment in Italy
OncoSil Medical (ASX:OSL) has announced the first patient treatment in Italy with its OncoSil device. |
BiotechDispatch | OSL | 11 months ago |
OncoSil Medical (ASX:OSL) treats first patient in Italy with flagship device
OncoSil Medical (OSL) treats its first patient in Italy with the Oncosil device, its flagship product for pancreatic cancer treatment The first patient treatment was carried out at the San Camilo-Forlanini Hospital in Rome, a significant... |
themarketherald.com.au | OSL | 11 months ago |
TMH Spotlight: OncoSil Medical (ASX:OSL) treats first patient in Italy, Iceni Gold (ASX:ICL) strikes high grade gold at Guyer
The ASX opened lower this morning, while majority of the sectors dragged. Finance and communications fell 0.5 per cent, while healthcare also took a hit – down 0.13 per cent. However, Amplia Therapeutics (ATX) appeared immune to the... |
themarketherald.com.au | OSL | 11 months ago |
Closing Bell: Its a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec... |
Stockhead | OSL | 1 year ago |